Nintendo Wii Virtual Reality Application In Dementia

Age-Related Memory Disorders Clinical Trial

Official title:

Nintendo Wii Virtual Reality Application In Older People With Alzheimer's Dementia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04819126
• Other study ID #: Karamanoglu Mehmet Bey U
• Secondary ID: Kirikkale Univer
• Status: Completed
• Phase: N/A
• Start date: January 15, 2018
• Est. completion date: January 15, 2019

Study information

• Verified date: March 2021
• Source: Kirikkale University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

•This study was planned to investigate the effects of the Nintendo Wii virtual reality application on muscle strength and fall risk in individuals with AD.

The aim of the present study is to investigate the effect of the virtual reality application on muscle strength and fall in individuals with Alzheimer' Dementia (AD).

Description:

Purpose: This study was planned to investigate the effects of the Nintendo Wii virtual reality application on muscle strength and fall risk in individuals with AD.

Method: The study included a total of 32 volunteers between the ages of 65-80, with mild or moderate AD diagnosed. These individuals were divided into 2 groups as a training group and control group. The training group was trained with games from different categories such as balance and aerobic exercises with a Nintendo Wii virtual reality device 2 times a week for a period of 6 weeks, with 1 session lasting for 30 minutes. Mini-Mental State Test, Knee Extension Muscle Strength, Timed Up and Go Test, Tinetti Falls Efficacy Scale results of individuals were recorded in the evaluation.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 32
• Est. completion date: January 15, 2019
• Est. primary completion date: June 6, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years to 80 Years

Eligibility

Inclusion Criteria:

• included volunteers between the ages of 65-80 with mild or moderate AD diagnosis,

• who did not have any difficulty or problems in communicating,

• who did not have any neurological diseases that disrupt balance and coordination such as a cerebrovascular event, Parkinson's disease, Multiple Sclerosis, and neurological disorder,

• who obtained a score of 18 - 24 points in the Mini-Mental State Test (MMST)

Exclusion Criteria:

• Patients diagnosed with rapidly progressing dementia (infection, vascular, hematologic diseases),

• Those who could not be contacted during the follow-up period or who did not participate in the training session, those who experienced cardiac and cerebrovascular events, endocrine disorders, fluid-electrolyte imbalance and infection,

• Those with malignancy and those who received chemotherapy and radiotherapy that causes malignancy, delirium or depression and malignant sensory loss (those with the Semmes-Weinstein monofilament thickness of 4.56 and above),

• Those with a lower or upper extremity amputation at any level

Related Conditions & MeSH terms

• Age-Related Memory Disorders
• Dementia
• Memory Disorders

Intervention

Other:
• Nintendo Wii Virtual Reality Application
The training group was trained with games from different categories such as balance and aerobic exercises with a Nintendo Wii virtual reality device 2 times a week for a period of 6 weeks, with 1 session lasting for 30 minutes.

Locations

Country	Name	City	State
Turkey	Karaman Ahmet Mete Nursing Home	Konya

Sponsors (1)

Lead Sponsor	Collaborator
Kirikkale University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Age :mean or median age	Age, Categorical: >=65 years	period of 6 weeks
Primary	Body Mass Index	BMI was recorded in kg/m^2.	period of 6 weeks
Primary	Sex/Gender	Sex: Female, Male	period of 6 weeks
Secondary	The Mini-Mental State Test for Cognitive status	According to the MMST, 24-30 points were considered as normal cognitive levels, 18-23 points were considered as mild cognitive disorders, and 0-17 points were considered as severe cognitive disorders	period of 6 weeks